Gene · 10765
Papers2,218
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,218
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dysregulated post‑translational modifications in granulosa cells drive ovarian dysfunction and potential infertility applications (Review). | Int J Mol Med | 2026 | 41716015 | PubTator, text mining | PubMed |
| ERRα-KDM5C restrains STING enhancer activity to modulate type I interferon signaling in breast cancer progression. | Cell Death Dis | 2026 | 41708589 | PubTator, text mining | PubMed |
| KDM5B cooperates with CRL4B complex to promote the tumorigenesis of ER+ breast cancer via regulating cholesterol metabolism. | Cell Death Dis | 2026 | 41654562 | PubTator, text mining | PubMed |
| Integrative Omics Analysis Reveals the Potential Value of CEACAM6 in Pan-Gastrointestinal Cancers. | Immun Inflamm Dis | 2026 | 41640009 | PubTator, text mining | PubMed |
| SUMOylation is destined for regulatory T cell-related immune dysregulation. | Cell Death Discov | 2026 | 41633969 | PubTator, text mining | PubMed |
| Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications. | Signal Transduct Target Ther | 2026 | 41582215 | PubTator, text mining | PubMed |
| Effect and Mechanism of Shenqi Lixin Formula on Angiogenesis and Glucose Metabolism in Rats With Heart Failure After Myocardial Infarction. | Clin Exp Pharmacol Physiol | 2026 | 41533967 | PubTator, text mining | PubMed |
| Gentianine suppresses renal cell carcinoma progression via direct interaction with KDM5B and ferroptosis activation. | Cell Signal | 2026 | 41371563 | PubTator, text mining | PubMed |
| Lysine methylation-mediated SMYD2 degradation by casticin sensitizes non-small-cell lung cancer cells to osimertinib therapy. | Biochem Pharmacol | 2026 | 41314435 | PubTator, text mining | PubMed |
| Integrating GWAS and machine learning for disease risk prediction in the Taiwanese Hakka population. | Front Genet | 2025 | 41427248 | PubTator, text mining | PubMed |
| Suppressing the OTUD7A/KDM5B/GABPA axis enhances the sensitivity of cisplatin through inducing ferroptosis in KRAS-mutant LUAD. | Cell Death Dis | 2025 | 41422226 | PubTator, text mining | PubMed |
| Human stem cell models for group 3 medulloblastoma uncover JARID1B as a regulator of the chromatin landscape. | bioRxiv | 2025 | 41415380 | PubTator, text mining | PubMed |
| A cancer-testis antigen signature for predicting prognosis and response to immunotherapy in acute myeloid leukemia. | Medicine (Baltimore) | 2025 | 41398765 | PubTator, text mining | PubMed |
| MicroLive: An Image Processing Toolkit for Quantifying Live-cell Single-Molecule Microscopy. | bioRxiv | 2025 | 41256434 | PubTator, text mining | PubMed |
| Histone probes for reader and eraser investigations. | Chem Sci | 2025 | 41164300 | PubTator, text mining | PubMed |
| Cuproptosis Facilitates Chronic Skin Inflammation by Regulating the α-Ketoglutarate/H3K4me3/Ferritin Heavy Chain 1 Signaling Pathway-Mediated Ferroptosis. | MedComm (2020) | 2025 | 41064128 | PubTator, text mining | PubMed |
| Discovery of actionable drug targets to enhance T-cell infiltration and immune checkpoint blockade efficacy in pleural mesothelioma. | Lung Cancer | 2025 | 41043322 | PubTator, text mining | PubMed |
| 3D Genome Architecture in Stem Cell Lineage Commitment: from Structural Organization to Precision Regulation. | Adv Genet (Hoboken) | 2025 | 41036476 | PubTator, text mining | PubMed |
| mcRigor: a statistical method to enhance the rigor of metacell partitioning in single-cell data analysis. | Nat Commun | 2025 | 41022768 | PubTator, text mining | PubMed |
| Roles of KDM5 demethylases in therapeutic resistance of cancers. | Epigenetics Chromatin | 2025 | 41013520 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10765/papers?page=3